Which Starter Dose Suits Your Weight Management Goals?
Understanding Wegovy and Mounjaro Starter Dose Differences
When comparing Wegovy and Mounjaro starter doses, the fundamental difference lies in their mechanisms and initial dosing approaches. Wegovy (semaglutide) begins with a 0.25mg weekly injection for weeks 1-4, designed as a gentle introduction to GLP-1 receptor stimulation. This lower starting dose helps minimise potential side effects whilst allowing your body to adapt to the medication's appetite-suppressing effects. Mounjaro (tirzepatide) starts at 2.5mg weekly, reflecting its dual GIP and GLP-1 receptor agonist mechanism that may require different dose calibration. The starter dose comparison shows both medicines follow evidence-based escalation protocols developed through extensive clinical trials.
The Wegovy starter dose of 0.25mg represents approximately one-tenth of the maintenance dose (2.4mg), emphasising the importance of gradual dose increases. This prescription-only medicine requires careful titration to achieve optimal effectiveness whilst maintaining tolerability. Mounjaro's 2.5mg starting point similarly represents the lowest therapeutic dose for its dual receptor mechanism. Neither dose can be skipped or accelerated, as clinical studies demonstrate that proper dose escalation is essential for both safety and long-term effectiveness in weight management.
Wegovy vs Mounjaro Starter Dose Pricing and Value Analysis
EverydayMeds offers transparent pricing for both Wegovy and Mounjaro starter doses, enabling informed treatment decisions. The Wegovy 0.25mg starter pen costs £79.99 for new customers using code FIRST40 at checkout, providing four weeks of treatment. Our Intro Duo bundle (0.25mg and 0.5mg pens) costs £169.99, covering the first eight weeks of your Wegovy journey with convenient single-order delivery. Mounjaro starter pricing follows a different structure reflecting its distinct dosing schedule and manufacturing requirements.
Both treatments require ongoing commitment beyond the starter dose phase, with Wegovy progressing through 0.5mg (£94.99), 1mg (£99.99), and 1.7mg (£139.99) before reaching the 2.4mg maintenance dose (£209.99). The complete dose comparison reveals different investment patterns for each treatment option. Returning customers benefit from code DOSE25 at checkout, whilst all orders include professional prescriber review through our GPhC-registered pharmacy (#9012878) and next-day cold-chain delivery to maintain medication integrity.
Clinical Evidence Behind Wegovy and Mounjaro Starter Dose Protocols
The STEP clinical trial programme established Wegovy's starter dose protocol through rigorous testing with over 4,500 participants. In STEP 1, patients following the complete dose escalation beginning with 0.25mg achieved an average 15% weight reduction at 68 weeks when combined with reduced-calorie diet and increased physical activity (Wilding et al., NEJM, 2021). The starter dose phase proved crucial for treatment adherence and side effect management.
Mounjaro's SURMOUNT trials similarly validated its 2.5mg starter dose approach, though direct head-to-head comparisons between the treatments aren't available due to different trial designs and populations. Both dose escalation protocols were developed to optimise the balance between therapeutic effectiveness and patient tolerability. The clinical evidence supports the importance of following prescribed starter dose schedules rather than attempting to accelerate treatment timelines.
How Wegovy's Starter Dose Mechanism Works
Wegovy's 0.25mg starter dose works by mimicking GLP-1, a natural hormone that regulates appetite and food intake. This prescription-only medicine binds to GLP-1 receptors in the brain, particularly in areas controlling hunger and satiety, helping reduce food cravings and promote feelings of fullness after smaller meals. The starter dose allows these receptors to gradually adapt to sustained GLP-1 stimulation, as Wegovy remains active for approximately one week compared to natural GLP-1's minutes-long duration. Even at this initial dose, many patients notice subtle changes in appetite patterns and meal satisfaction. The 0.25mg dose also slows gastric emptying, helping food remain in the stomach longer and contributing to enhanced satiety signals.
Wegovy and Mounjaro Starter Dose Ordering Process
Beginning treatment with either Wegovy or Mounjaro starter doses requires completion of our comprehensive 3-minute clinical assessment covering medical history, current medications, and weight management goals. Our qualified prescribers review each application within 3 working days (or 24 hours with express service), ensuring appropriate treatment selection based on individual circumstances. Once approved, your starter dose ships via next-day delivery using temperature-controlled cold-chain logistics to maintain medication stability. The online process eliminates traditional pharmacy visits whilst maintaining full clinical oversight through our GPhC-registered service (#9012878). Payment is secured at checkout using codes FIRST40 (new customers) or DOSE25 (returning customers) to access our competitive starter dose pricing.
Storage and Practical Considerations for Starter Doses
Both Wegovy and Mounjaro starter doses require refrigeration at 2-8°C until first use, but their room temperature storage capabilities differ significantly. Wegovy pens can remain at room temperature (below 30°C) for up to 6 weeks once removed from refrigeration, offering superior convenience for travel or flexible storage. Mounjaro allows only 21 days at room temperature, making Wegovy more practical for extended trips or variable storage situations. Both treatments use simple injection pens with clear dosing mechanisms, though the starter doses involve different pen designs reflecting their distinct formulations. The Wegovy 0.25mg FlexTouch pen provides precise dose delivery with minimal training required, whilst proper injection technique training is provided with your first prescription.
Comparing Wegovy and Mounjaro Starter Dose Escalation Timelines
The most significant difference in starter dose comparison involves escalation timing and target maintenance doses. Wegovy follows a 16-week escalation schedule: 0.25mg (weeks 1-4), 0.5mg (weeks 5-8), 1mg (weeks 9-12), 1.7mg (weeks 13-16), then 2.4mg maintenance. This gradual approach allows careful monitoring of tolerance and effectiveness at each stage. Mounjaro follows a different timeline with 2.5mg for four weeks, then escalating to 5mg, 10mg, and potentially 15mg based on clinical response.
Neither treatment allows dose escalation acceleration, as clinical trials demonstrated that following prescribed schedules optimises long-term outcomes. The starter dose comparison reveals that both treatments require approximately four months to reach maintenance dosing, though the specific dose levels and timing intervals differ. Your prescriber will monitor progress throughout the escalation phase, potentially adjusting timing based on individual tolerance and effectiveness indicators.
Making Your Wegovy vs Mounjaro Starter Dose Decision
Choosing between Wegovy and Mounjaro starter doses involves multiple factors beyond initial pricing and dosing schedules. Wegovy's extensive clinical evidence base includes cardiovascular outcomes data (SELECT trial), showing 20% reduction in major cardiovascular events, which may influence decisions for patients with existing cardiovascular risk factors. The storage advantage of 6 weeks room temperature tolerance makes Wegovy more suitable for patients with travel requirements or variable storage conditions. Both treatments are available from EverydayMeds, and your prescriber can help determine which option aligns with your medical history, lifestyle requirements, and weight management goals.
The starter dose comparison ultimately represents the beginning of a long-term weight management commitment, as both treatments require ongoing use to maintain effectiveness. Clinical studies demonstrate that discontinuing either treatment typically results in weight regain, emphasising the importance of selecting a sustainable option from the outset. Your EverydayMeds clinical assessment will consider factors including previous weight loss attempts, current medications, medical conditions, and personal preferences to recommend the most appropriate starter dose option for your individual circumstances.
Ready to begin your weight management journey? Complete our 3-minute clinical assessment to determine whether Wegovy or Mounjaro starter dose is right for you. New customers save with code FIRST40, whilst returning customers use DOSE25 at checkout. Our qualified prescribers provide expert guidance through the entire process, from starter dose selection through maintenance therapy. Order your starter dose today and benefit from next-day delivery, professional clinical support, and transparent pricing through our GPhC-registered pharmacy.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
